MedTrace Logo

The Effectiveness of Systane PRO Preservative Free Verses Blink Triple Care Preservative Free

NCT07745062 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-08-04

No results posted yet for this study

Summary

The goal of this investigational study is to determine if Systane PRO Preservative Free is non-inferior to BLINK TRIPLE CARE in the clinically significant improvement of signs and symptoms of dry eye in patients over 4 weeks.

Conditions

  • Dry Eye Disease (DED)

Interventions

DRUG

Systane PRO

Administer Systane Pro PF QID OU over a period of 30 days

DRUG

Blink tears

Administer Blink Triple Care PF QID OU over a period of 30 days

Sponsors & Collaborators

  • Gordon Schanzlin New Vision

    lead OTHER

Principal Investigators

  • David I Geffen, Doctor Of Optometry · Gordon Schanzlin New Vision Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-17
Primary Completion
2027-01-01
Completion
2027-04-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07745062 on ClinicalTrials.gov